Your browser doesn't support javascript.
CLINICAL PRACTICE INSIGHTS DELIVERING CARE DURING COVID IN FIVE EUROPEAN COUNTRIES UTILIZING A PROFESSIONAL DIABETES MANAGEMENT ECOSYSTEM
Diabetes Technology and Therapeutics ; 24(SUPPL 1):A167, 2022.
Article in English | EMBASE | ID: covidwho-1896149
ABSTRACT
Background and

Aims:

Connecting in-person with patients is challenging during COVID, potentially undermining the frequency and quality of consultations with health care professionals (HCPs). Telemedicine offers a way to support patient provider connectivity.

Methods:

Survey data was collected from 22 HCPs from 20 institutions who then participated in one of four virtual meetings to share telemedicine insights using the professional version of One Touch Reveal® (OTR Pro) ecosystem.

Results:

Remote consultations increased 46% in these institutions during COVID, divided 52% and 48% between patients with type 1 and type 2 diabetes. Methods included telephone (60%), email (19%), video (10%), texting (3%), or combinations (8%). HCPs reviewed OTR Pro data during (45%) or before (25%) consultations, every 3 months (20%) or every 2 weeks (5%). 55% of HCPs said going forward, OTR Pro would become their standard of care, 30% for current or new patients, 10%during face-to-face visits and only 5% returning to face-to-face consultations without OTR Pro. For managing patients, HCPs ranked ''allows me to make treatment/therapy decisions,'' ''helps me schedule consultations/ reminders,'' ''access 24/7 to status of my patients,'' as the top 3 benefits of OTR Pro. 95% of HCPs agreed OTR Pro identified patterns, trends and trouble spots for more meaningful conversations with patients, facilitating clinical practice during COVID.

Conclusions:

The One Touch Reveal® ecosystem supported telemedicine during the pandemic and will continue to play a valuable role beyond the pandemic.
Keywords

Full text: Available Collection: Databases of international organizations Database: EMBASE Type of study: Prognostic study Language: English Journal: Diabetes Technology and Therapeutics Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: EMBASE Type of study: Prognostic study Language: English Journal: Diabetes Technology and Therapeutics Year: 2022 Document Type: Article